Literature DB >> 9299458

Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells.

T Murata1, N I Obiri, W Debinski, R K Puri.   

Abstract

The structure of IL-13 receptor (IL-13R) is currently under investigation. Recently, two different human IL-13R chains, termed here IL-13R alpha and -alpha' have been cloned. We have examined various cancer and normal cell lines for the presence of mRNA for IL-13R alpha and alpha, as well as IL-4R p140 (termed beta chain) and IL-2R gamma c chains. In renal cell carcinoma, glioblastoma and ovarian carcinoma (IGROV-1) cell lines, both IL-13R alpha and alpha chains were expressed (type I IL-13R). In epidermoid, colon, ovarian adenocarcinoma (PA-1) and normal mouse fibroblast (COS7) cell lines, only IL-13R alpha' was expressed (type II IL-13R). In hematopoietic TF-1 and EBV-immortalized normal B cell lines only IL-13R alpha' but not alpha chain was expressed along with gamma c (type III or type IV IL-13R). IL-13R alpha' chain was faintly detected in human T cells. All cells expressed the IL-4Rp140 beta chain. These data provide a direct support for our model of IL-13R which consists of three different forms composed of different subunits.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299458     DOI: 10.1006/bbrc.1997.7248

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Interleukin-13 receptor subunit alpha-2 is a target of progesterone receptor and steroid receptor coactivator-1 in the mouse uterus†.

Authors:  Ryan M Marquardt; Kevin Lee; Tae Hoon Kim; Brandon Lee; Francesco J DeMayo; Jae-Wook Jeong
Journal:  Biol Reprod       Date:  2020-10-05       Impact factor: 4.285

2.  Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency.

Authors:  David B Corry; Kirtee Rishi; John Kanellis; Attila Kiss; Li-zhen Song Lz; Jie Xu; Lili Feng; Zena Werb; Farrah Kheradmand
Journal:  Nat Immunol       Date:  2002-03-11       Impact factor: 25.606

3.  Genetic reprogramming of tumor cells by zinc finger transcription factors.

Authors:  Pilar Blancafort; Emily I Chen; Beatriz Gonzalez; Sharon Bergquist; Andries Zijlstra; Daniel Guthy; Arndt Brachat; Ruud H Brakenhoff; James P Quigley; Dirk Erdmann; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

4.  Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.

Authors:  V A Kuznetsov; R K Puri
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

5.  Molecular cloning of the rat IL-13 alpha 2 receptor cDNA and its expression in rat tissues.

Authors:  An-Hua Wu; Walter C Low
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

6.  Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia.

Authors:  C Jakubzick; E S Choi; S L Kunkel; H Evanoff; F J Martinez; R K Puri; K R Flaherty; G B Toews; T V Colby; E A Kazerooni; B H Gross; W D Travis; C M Hogaboam
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

7.  Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.

Authors:  Edwin W Lai; Bharat H Joshi; Lucia Martiniova; Ritika Dogra; Toshio Fujisawa; Pamela Leland; Ronald R de Krijger; Irina A Lubensky; Abdel G Elkahloun; John C Morris; Raj K Puri; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2009-06-02       Impact factor: 5.958

8.  An immune cell-selective interleukin 4 agonist.

Authors:  A B Shanafelt; C P Forte; J J Kasper; L Sanchez-Pescador; M Wetzel; R Gundel; J M Greve
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer.

Authors:  Z Zhao; L Wang; W Xu
Journal:  Oncogene       Date:  2014-04-21       Impact factor: 9.867

10.  Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A.

Authors:  Rogério S Rosada; Ana P Moreira; Fabiani G Frantz; Raj K Puri; Aquilur Rahman; Theodore J Standiford; Carlos R Zárate-Bladés; Célio L Silva; Cory M Hogaboam
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.